foxo4-dri patent The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4-DRI — 10mg | D-Retro-Inverso
FOXO4 DRI 10mg D Retro Inverso PPI Peptide VPeptide FOXO4 DRI Canada: Ultra Pure Peptide for Senolytic, Cellular Aging & Longevity Pathway Research Targeted Apoptosis of Senescent Cells Restores Tissue Homeostasis in Response to Chemotoxicity and Aging: Cell Buy FOXO4 DRI 10mg Peptide EU Tested Particle Peptides FOXO4 DRI Peptide 10 mg
Pay in 4 interest-free payments of $5.64 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 26 - Oct 1



